Latest News
-
FamPlex: A Resource for Entity Recognition and Relationship Resolution of Human Protein Families and Complexes in Biomedical Text Mining
June 28, 2018
-
Encoding Growth Factor Identity in the Temporal Dynamics of FOXO3 under the Combinatorial Control of ERK and AKT Kinases
May 31, 2018
-
A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling
March 19, 2018
-
Inflammatory but not Mitogenic Contexts Prime Synovial Fibroblasts for Compensatory Signaling Responses to p38 Inhibition
March 6, 2018
-
Multiplexed Immunofluorescence Reveals Potential PD-1/PD-L1 Pathway Vulnerabilities in Craniopharyngioma
March 2, 2018
-
Small-Molecule Screen Identifies De Novo Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3
February 20, 2018
-
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
December 14, 2017
-
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
November 24, 2017
-
From Word Models to Executable Models of Signaling Networks Using Automated Assembly
November 24, 2017
-
Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics
November 7, 2017
|
Fallahi-Sichani M, Honarnejad S, Heiser LM, Gray JW, and Sorger PK (2013). Metrics Other Than Potency Reveal Systematic Variation in Responses to Cancer Drugs. Nat Chem Biol 9(11), 708-714. PMC3947796 PMID: 24013279. Abstract
Large-scale analysis of cellular response to anticancer drugs typically focuses on variation in potency (half-maximum inhibitory concentration, (IC50)), assuming that it is […]
Niepel M, Hafner M, Pace EA, Chung M, Chai DH, Zhou L, Schoeberl B, and Sorger PK (2013). Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines. Sci Signal 6(294), ra84. PMC3845839 PMID: 24065145. Abstract
Identifying factors responsible for variation in drug response is essential for the effective use […]
Sarosiek KA, Chi X, Bachman JA, Sims JJ, Montero J, Patel L, Flanagan A, Andrews DW, Sorger P, and Letai A (2013). BID Preferentially Activates BAK While BIM Preferentially Activates BAX, Affecting Chemotherapy Response. Mol Cell 51(6), 751-765. PMID: 24074954. Abstract
Apoptosis is a highly regulated form of cell death that controls normal homeostasis as […]
Paull EO, Carlin DE, Niepel M, Sorger PK, Haussler D, and Stuart JM (2013). Discovering Causal Pathways Linking Genomic Events to Transcriptional States Using Tied Diffusion through Interacting Events (TieDIE). Bioinformatics PMC3799471 PMID: 23986566. Abstract
MOTIVATION: Identifying the cellular wiring that connects genomic perturbations to transcriptional changes in cancer is essential to gain a mechanistic […]
Marco E, Dorn JF, Hsu PH, Jaqaman K, Sorger PK, and Danuser G (2013). S. Cerevisiae Chromosomes Biorient Via Gradual Resolution of Syntely between S Phase and Anaphase. Cell 154(5), 1127-1139. PMC3802543 PMID: 23993100. Abstract
Following DNA replication, eukaryotic cells must biorient all sister chromatids prior to cohesion cleavage at anaphase. In animal cells, sister […]
Gujral TS, Karp RL, Finski A, Chan M, Schwartz PE, Macbeath G, and Sorger P (2013). Profiling Phospho-Signaling Networks in Breast Cancer Using Reverse-Phase Protein Arrays. Oncogene PMC3670968 PMID: 22945653. Abstract
Measuring the states of cell signaling pathways in tumor samples promises to advance the understanding of oncogenesis and identify response biomarkers. Here, we describe […]
Flusberg DA, and Sorger PK (2013). Modulating Cell-to-Cell Variability and Sensitivity to Death Ligands by Co-Drugging. Phys Biol 10(3), 035002. PMC3775495 PMID: 23735516. Abstract
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) holds promise as an anti-cancer therapeutic but efficiently induces apoptosis in only a subset of tumor cell lines. Moreover, even in clonal populations of responsive […]
Bagci-Onder T, Agarwal A, Flusberg D, Wanningen S, Sorger P, and Shah K (2013). Real-Time Imaging of the Dynamics of Death Receptors and Therapeutics That Overcome TRAIL Resistance in Tumors. Oncogene PMC3676868 PMID: 22824792. Abstract
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces apoptosis specifically in tumor cells and its efficacy has been tested in […]
Flusberg DA, Roux J, Spencer SL, and Sorger PK (2013). Cells Surviving Fractional Killing by TRAIL Exhibit Transient but Sustainable Resistance and Inflammatory Phenotypes. Mol Biol Cell PMC3708725 PMID: 23699397. Abstract
When clonal populations of human cells are exposed to apoptosis-inducing agents, some cells die and others survive. This fractional killing arises not from mutation […]
McAllister FE, Niepel M, Haas W, Huttlin E, Sorger PK, and Gygi SP (2013). Mass Spectrometry Based Method to Increase Throughput for Kinome Analyses Using ATP Probes. Anal Chem 85(9), 4666-4674. PMC3771683 PMID: 23607489. Abstract
Protein kinases play critical roles in many biological and pathological processes, making them important targets for therapeutic drugs. Here, we […]
|
|